P1.22-16 ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments

Autor: Robado de Lope, L., Serna-Blasco, R., Mediavilla, P., Sanz-Moreno, S., Rodríguez-Festa, A., Gallego-Gil, P., Flores, C., Calvo, V., Collazo-Lorduy, A., Blanco, M., Peña Cabia, S., Diz Tain, P., Garrido Onecha, M.L., Sánchez-Hernández, A., Sequero López, S., Rogado, J., Coves Sarto, J., López Martín, A., Mielgo, X., Vázquez Estévez, S., González-Rumayor, V., Romero, A., Provencio, M.
Zdroj: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S252-S252
Databáze: ScienceDirect